We are live on ! Find out more
LCM

Laurion Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 75.73%
This Fund
S&P 500
This Quarter Est. Return
+0.46%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$10.2B
AUM Growth
+$2.71B
Cap. Flow
+$2.52B
Cap. Flow %
24.8%
Top 10 Hldgs %
22.77%
Holding
1,327
New
518
Increased
196
Reduced
137
Closed
463

Top Buys

Rank Stock Value
1
AABA
Altaba Inc
AABA
+$231M
2
MRK icon
Merck
MRK
+$89.7M
3
LYB icon
LyondellBasell Industries
LYB
+$46.9M
4
BIDU icon
Baidu
BIDU
+$45.2M
5
CTVA icon
Corteva
CTVA
+$41M

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$226M
2
WFC icon
Wells Fargo
WFC
+$90.4M
3
ELAN icon
Elanco Animal Health
ELAN
+$80.8M
4
PTC icon
PTC
PTC
+$64.2M
5
LULU icon
lululemon athletica
LULU
+$52.7M

Sector Composition

Rank Sector Weight
1 Healthcare 5.54%
2 Technology 4.25%
3 Industrials 2.04%
4 Materials 1.4%
5 Financials 1.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHF icon
901
Brighthouse Financial
BHF
$3.5B
-46,436
Closed -$1.69M
BILI icon
902
Bilibili
BILI
$7.84B
-95,529
Closed -$1.81M
BIO icon
903
Bio-Rad Laboratories Class A
BIO
$9.42B
-1,100
Closed -$336K
BNY
904
Bank of New York Mellon
BNY
$107B
-391,100
Closed -$19.7M
BNY
905
PUT
Bank of New York Mellon
BNY
$107B
-1,600
Closed -$81K
BKD icon
906
Brookdale Senior Living
BKD
$3.4B
-212,742
Closed -$1.4M
BKU icon
907
Bankunited
BKU
$3.36B
-49,439
Closed -$1.65M
BLFS icon
908
BioLife Solutions
BLFS
$1.7B
-84,944
Closed -$1.52M
BLMN icon
909
Bloomin' Brands
BLMN
$938M
-87,293
Closed -$1.78M
BMI icon
910
Badger Meter
BMI
$4.03B
-10,882
Closed -$605K
BPMC
911
DELISTED
Blueprint Medicines
BPMC
-261,904
Closed -$21M
BTU icon
912
Peabody Energy
BTU
$2.9B
-17,321
Closed -$491K
BXP icon
913
Boston Properties
BXP
$11.1B
-13,361
Closed -$1.79M
CABO icon
914
Cable One
CABO
$212M
-1,907
Closed -$1.87M
CALM icon
915
Cal-Maine
CALM
$3.99B
-13,000
Closed -$580K
CANG
916
Cango Inc
CANG
$68.5M
-3,690
Closed -$251K
CASH icon
917
Pathward Financial
CASH
$1.8B
-17,453
Closed -$343K
CAT icon
918
PUT
Caterpillar
CAT
$387B
-16,900
Closed -$2.29M
CATY icon
919
Cathay General Bancorp
CATY
$4.24B
-9,748
Closed -$331K
CBSH icon
920
Commerce Bancshares
CBSH
$8.5B
-19,834
Closed -$818K
CCL icon
921
CALL
Carnival Corporation Ltd
CCL
$39.7B
-50,200
Closed -$2.55M
CCL icon
922
Carnival Corporation Ltd
CCL
$39.7B
-23,744
Closed -$1.2M
CCL icon
923
PUT
Carnival Corporation Ltd
CCL
$39.7B
-75,900
Closed -$3.85M
CCRN
924
DELISTED
Cross Country Healthcare
CCRN
-21,514
Closed -$151K
CENT icon
925
Central Garden & Pet Co
CENT
$2.8B
-21,453
Closed -$439K

Similar funds

Laurion Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Laurion Capital Management held 1,327 positions worth $10.2B, up 36% from $7.45B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Laurion Capital Management deployed $2.52B of net new capital in Q2 2019, opening 518 new positions and adding to 196 existing holdings. Its largest new stake was Altaba Inc: 3,302,955 shares worth $229M.

By sector, the portfolio is most concentrated in Healthcare at 5.5% of assets, down from 5.6% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Wells Fargo, an estimated $90.4M trimmed.

  • Laurion Capital Management's largest Q2 2019 buy was Altaba Inc: 3,302,955 shares worth $229M.
  • Laurion Capital Management added most to Baidu in Q2 2019, an estimated $45.2M increase.
  • Laurion Capital Management's biggest Q2 2019 reduction was Wells Fargo, cutting an estimated $90.4M.
  • Laurion Capital Management fully exited Walt Disney in Q2 2019, selling an estimated $226M.
  • Laurion Capital Management's ten largest holdings make up 23% of its $10.2B portfolio in Q2 2019.
  • Laurion Capital Management opened 518 new positions and closed 463 in Q2 2019.
  • Laurion Capital Management's portfolio value rose 36% quarter-over-quarter to $10.2B.

Based on Laurion Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.